Skip to main contentSkip to footer

Replace late surprises with early certainty

ORYL F1 is a high-throughput, low-compound, plate-based solubility and aggregation profiling instrument, powered by Ultrafast Light Scattering (ULS).

ORYL F1 instrument — plate-based solubility and aggregation profiling
384 wells
Profiled in 15 minutes
~100×
Less compound required vs HPLC-based methods
<1 hour
from measurement to decision-ready insights
Why ORYL

De-risk solubility and aggregation early

The Challenge

Late surprises derail drug development

Traditional solubility and aggregation workflows are slow, compound-hungry, and often deliver answers too late in the pipeline to make a difference.

  • Low throughput limits screening coverage
  • High compound consumption restricts early-stage testing
  • Late-stage solubility failures cause costly rework
  • Limited sensitivity misses early aggregation signals
The ORYL Solution

Decision-ready results, early and fast

ORYL F1 delivers high-throughput, low-compound solubility and aggregation profiling powered by Ultrafast Light Scattering, enabling better decisions from discovery through formulation.

  • Profile 384 wells in 15 minutes
  • Use roughly 100× less compound than HPLC workflows
  • Detect nanometer-scale aggregation before visible turbidity
  • Plate-based format fits existing lab workflows
The ORYL F1

Built for modern pharma R&D

The ORYL F1 is the first plate-based instrument to combine second harmonic scattering (SHS) and linear light scattering (LLS) in a single, high-throughput platform. From early discovery screening to pre-formulation profiling, the ORYL F1 delivers robust and reliable measurements that match pharma R&D timelines.

384-well
Plate-based format
~15 min
Full plate measurement
SHS + LLS
Complementary readouts
High-sensitivity
Nanometer-scale detection
Measurement Services

Validate every compound — not just your lead

Let ORYL run the measurements for you. Send your samples and evaluate ORYL F1 data before bringing the instrument in-house. Ideal for teams needing rapid results.

Decision-ready
PDF Report, CSV, JSON, PLOT
2 weeks
turnaround time
USD 30-50
per compound
Applications

From discovery to formulation

From hit-list screening in early discovery to formulation window mapping in pre-formulation, ORYL F1 supports the workflows that matter.

Technology

Powered by Ultrafast Light Scattering (ULS)

ORYL F1 combines second harmonic scattering (SHS) and linear light scattering (LLS) into a single measurement platform, offering complementary readouts that reveal molecular-level insight into solubility and aggregation behavior.

Second Harmonic Scattering (SHS)

Probes molecular-level organization and early-onset aggregation events invisible to conventional light scattering methods.

Linear Light Scattering (LLS)

Complements SHS with established scattering measurements to characterize particle size and aggregation growth with high sensitivity.

High-Sensitivity Detection

Detect subtle changes at the nanometer scale — early onset of aggregation prior to turbidity — giving teams earlier and more actionable insight.

Plate-Based, High-Throughput

Profile hundreds of conditions in minutes using standard 384-well plates, matching the pace of modern pharma R&D timelines.

FAQ

Common questions about the ORYL Photonics

The ORYL F1 is a high-throughput, low-compound, plate-based solubility and aggregation profiling instrument for pharma R&D, powered by Ultrafast Light Scattering (ULS).

ULS combines Second Harmonic Scattering (SHS) and Linear Light Scattering (LLS) on the same sample — complementary readouts that detect the early onset of aggregation before turbidity and define the solubility limit.

It profiles solubility and aggregation about 100x faster and with about 100x less compound than HPLC, and works above 50 mg/mL where DLS saturates. It is an alternative that runs before and alongside them, not a replacement.

Ready to de-risk early?

See how ORYL F1 can deliver decision-ready solubility and aggregation results for your pipeline.